Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
57.32
-1.10 (-1.88%)
Apr 10, 2026, 4:00 PM EDT - Market closed
Haemonetics Employees
Haemonetics had 3,023 employees as of March 29, 2025. The number of employees decreased by 634 or -17.34% compared to the previous year.
Employees
3,023
Change (1Y)
-634
Growth (1Y)
-17.34%
Revenue / Employee
$436,082
Profits / Employee
$58,034
Market Cap
2.66B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 29, 2025 | 3,023 | -634 | -17.34% |
| Mar 30, 2024 | 3,657 | 623 | 20.53% |
| Apr 1, 2023 | 3,034 | 213 | 7.55% |
| Apr 2, 2022 | 2,821 | 113 | 4.17% |
| Apr 3, 2021 | 2,708 | -296 | -9.85% |
| Mar 28, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 1, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 2, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Integer Holdings | 11,000 |
| AdaptHealth | 10,900 |
| LivaNova | 3,300 |
| Neogen | 2,974 |
| iRhythm Holdings | 2,400 |
| Artivion | 1,800 |
| Inspire Medical Systems | 1,333 |
| Establishment Labs Holdings | 1,004 |
HAE News
- 11 days ago - Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026 - PRNewsWire
- 13 days ago - Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System - PRNewsWire
- 6 weeks ago - Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology - PRNewsWire
- 7 weeks ago - Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference - PRNewsWire
- 2 months ago - These Analysts Revise Their Forecasts On Haemonetics After Q3 Earnings - Benzinga
- 2 months ago - Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website - PRNewsWire
- 3 months ago - Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics - GlobeNewsWire
- 3 months ago - Vivasure Medical Announces Acquisition by Haemonetics Corporation - Business Wire